Quest Diagnostics' Q4 Revenues up 7 Percent | GenomeWeb

NEW YORK (GenomeWeb) – Quest Diagnostics today posted a 7 percent rise in fourth quarter revenues, topping analysts' estimates and helping drive an increase in its net income.

Quest's revenues from continuing operations were $1.88 billion for the three-month period ended Dec. 31, compared with year-ago revenues of $1.76 billion. Analysts had expected revenues of $1.85 billion.

The company said revenues from diagnostic information services climbed 7 percent over last year, while test volume around 9 percent. Revenue per requisition was nearly 2 percent lower than a year ago.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Startup companies are taking on personalized medicine, CNET reports.

Bruce Booth writes at Life Sci VC that biotech clusters like Boston and San Francisco are getting even more consolidated.

The Verge speaks with Mark and Scott Kelly, who are the subjects of NASA's Twin Study.

In Genome Biology this week: genes linked to Hirschsprung disease, structural variant patterns in autism, and more.